| Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. (NCT06394232) | Eyestem Research Pvt. Ltd. | 2024-06-04 |
| A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer (NCT06457919) | Memorial Sloan Kettering Cancer Center | 2024-06-04 |
| Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancies (NCT06199479) | M.D. Anderson Cancer Center | 2024-06-04 |
| Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 (NCT06283459) | Imunon | 2024-06-04 |
| A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection (NCT06384131) | Assembly Biosciences | 2024-06-04 |
| Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients (NCT06389695) | Norroy Bioscience Co., LTD | 2024-06-04 |
| A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body (NCT06393127) | Boehringer Ingelheim | 2024-06-04 |
| Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It. (NCT06905496) | Nishtar Medical University | 2024-06-03 |
| PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers (NCT06435442) | JW Pharmaceutical | 2024-06-03 |
| SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Females (NCT06467201) | Amneal Pharmaceuticals, LLC | 2024-06-03 |
| A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease (NCT06413511) | GlaxoSmithKline | 2024-06-03 |
| A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies (NCT06507306) | Kumquat Biosciences Inc. | 2024-06-03 |
| A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection (NCT06159062) | Yangshengtang Co., Ltd | 2024-06-03 |
| Mesenchymal Stem Cells for Frailty Syndrome (NCT06501066) | Meribank Biotech Co., Ltd. | 2024-06-03 |
| Impact of Competency-Based Training and Technical Assistance Employment Outcomes of Individuals With ID/DD (NCT06586827) | Virginia Commonwealth University | 2024-06-03 |
| Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment (NCT06671444) | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | 2024-06-03 |
| A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults (NCT06612255) | Melinta Therapeutics, Inc. | 2024-06-03 |
| A Study of BND-35 in Participants With Advanced Solid Tumors (NCT06274437) | Biond Biologics | 2024-06-02 |
| L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma (NCT06478381) | Henan Cancer Hospital | 2024-06-01 |
| Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders (NCT05909943) | Tianjin Medical University General Hospital | 2024-06-01 |
| The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome (NCT06393101) | University of California, San Diego | 2024-06-01 |
| Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 (NCT06312761) | University of Washington | 2024-06-01 |
| Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma (NCT05973903) | Tel Aviv Medical Center | 2024-06-01 |
| Safety and Tolerability Studies of CanProFem-AK, Vaginal Suppositories in Healthy Volunteers (NCT06535126) | Industrial Microbiology LLP | 2024-06-01 |
| ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck (NCT06357858) | Case Comprehensive Cancer Center | 2024-06-01 |
| Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) (NCT06482268) | University of California, San Diego | 2024-06-01 |
| Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma (NCT05788107) | Shanghai Henlius Biotech | 2024-06-01 |
| Cadonilimab in Combination With Ramucirumab for the Treatment of Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy (NCT05856864) | Tianjin Medical University Cancer Institute and Hospital | 2024-06-01 |
| Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis (NCT06302049) | Sadat City University | 2024-06-01 |
| Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers (NCT05153304) | University of California, San Diego | 2024-06-01 |
| Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841 (NCT06219499) | OncoC4, Inc. | 2024-06-01 |
| Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma (NCT06961617) | Lion TCR Pte. Ltd. | 2024-06-01 |
| Diabetes Islet Preservation Immune Treatment (NCT02586831) | Camillo Ricordi and Jay Skyler | 2024-06-01 |
| Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance (NCT05136963) | Centre Hospitalier Universitaire de Saint Etienne | 2024-06-01 |
| Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma (NCT06470256) | Zhiyong Huang | 2024-06-01 |
| Radiotherapy to All Residual Lesions After Chemoimmunotherapy (NCT06479473) | Anhui Provincial Hospital | 2024-06-01 |
| Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models (NCT06463444) | Chen Xiaoping | 2024-06-01 |
| A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B (NCT06452693) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-06-01 |
| Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid Leukemia (NCT05319249) | German Cancer Research Center | 2024-06-01 |
| Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment (NCT06304025) | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | 2024-06-01 |
| A Single Dose Escalation Study of HHT201 in Healthy Subjects (NCT06373094) | Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | 2024-06-01 |
| A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome. (NCT06396013) | Beijing Hospital of Traditional Chinese Medicine | 2024-06-01 |
| Efficacy of Pure Honey Dressing in Contrast to Alvogyl in the Resolution of Dry Socket (NCT06456060) | Watim Medical & Dental College | 2024-06-01 |
| The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer (NCT06856447) | toqa saad mohammed mohammed | 2024-06-01 |
| A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer (NCT06415903) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-06-01 |
| T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) (NCT06343311) | Estrella Biopharma, Inc. | 2024-06-01 |
| Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients (NCT04729582) | Simone Spuler, MD | 2024-06-01 |
| Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation. (NCT06197763) | St. Boniface Hospital | 2024-06-01 |
| Fortified Oral Rehydration Therapy for Pediatric Diarrhea (NCT06137014) | Paul A Breslin | 2024-06-01 |
| A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C (NCT05975021) | Windtree Therapeutics | 2024-06-01 |
| Does Successive Intra-articular Injections of Tenoxicam or Meloxicam Affect Treatment of TMJ Displacement (NCT06403046) | Beni-Suef University | 2024-06-01 |
| Safety and Efficacy of Treg Cell in the Treatment of GVHD (NCT06411184) | Xuzhou Medical University | 2024-06-01 |
| Evaluation of CYT-108, A Recombinant Protease Inhibitor, for Treatment of Mild To Moderate Primary Osteoarthritis Of The Knee (NCT06263270) | Cytonics Corporation | 2024-06-01 |
| Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients (NCT06945679) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2024-06-01 |
| An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency (NCT07644832) | Shanghai RAAS Blood Products Co., Ltd. | 2024-05-31 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Participants, Healthy Elderly Participants, and Healthy Participants of Japanese Ethnicity (NCT06411730) | Celgene | 2024-05-31 |
| Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants (NCT06495944) | Corcept Therapeutics | 2024-05-31 |
| Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors (NCT05887882) | Sabine Mueller, MD, PhD | 2024-05-31 |
| NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma (NCT06420349) | Mayo Clinic | 2024-05-31 |
| Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction (NCT06383897) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-05-31 |
| CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL (NCT06445803) | Rong Tao | 2024-05-31 |
| Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors (NCT06337084) | Monopar Therapeutics | 2024-05-30 |
| Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects. (NCT06569784) | Xizang Haisco Pharmaceutical Co., Ltd | 2024-05-30 |
| R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma (NCT06594640) | Institute of Hematology & Blood Diseases Hospital, China | 2024-05-30 |
| A Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors (NCT07131189) | Suzhou Forlong Biotechnology Co., Ltd | 2024-05-30 |
| A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes (NCT06385327) | Assembly Biosciences | 2024-05-30 |
| Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis (NCT06106672) | COUR Pharmaceutical Development Company, Inc. | 2024-05-30 |
| QTX3046 in Patients With KRAS G12D Mutations (NCT06428500) | Quanta Therapeutics | 2024-05-30 |
| The Effects of Vitamin B6 Supplementation on Pain Thresholds and Tolerance (NCT06415383) | University of Reading | 2024-05-30 |
| A Study to Evaluate the Drug Levels, Metabolism and Excretion, and Absolute Bioavailability of BMS-986365 in Healthy Male Participants (NCT06433505) | Celgene | 2024-05-30 |
| A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors (NCT06037317) | Shouyao Holdings (Beijing) Co. LTD | 2024-05-30 |
| Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma. (NCT06320080) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-05-30 |
| A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease (NCT06401044) | Amgen | 2024-05-30 |
| A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET (NCT06476509) | Vigonvita Life Sciences | 2024-05-30 |
| A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors (NCT06390774) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-05-30 |
| ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer (NCT06328738) | Enliven Therapeutics | 2024-05-30 |
| Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter) (NCT06328712) | ENCell | 2024-05-30 |
| A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects (NCT07508462) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-05-30 |
| Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. (NCT06372626) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-05-30 |
| SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor (NCT06350006) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-05-29 |
| Safety, Tolerability and Pharmacokinetics of CDD-2101 in Health Volunteers (NCT06570668) | Centre for Chinese Herbal Medicine Drug Development Limited | 2024-05-29 |
| Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases (NCT06428188) | Essen Biotech | 2024-05-29 |
| Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia (NCT06366789) | Lomond Therapeutics Holdings, Inc. | 2024-05-29 |
| A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine (NCT06465420) | InventVacc Biologicals Inc. | 2024-05-29 |
| Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya (NCT06263582) | UNC Lineberger Comprehensive Cancer Center | 2024-05-29 |
| A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) (NCT06360354) | Amgen | 2024-05-29 |
| A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer (NCT06471673) | BriaCell Therapeutics Corporation | 2024-05-29 |
| Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors (NCT06504368) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2024-05-29 |
| A Trial to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]-Darigabat After a Single Oral Dose in Healthy Male Participants (NCT06435923) | Cerevel Therapeutics, LLC | 2024-05-29 |
| Pilot Study of AVT16 in Healthy Adult Subjects (NCT06400719) | Alvotech Swiss AG | 2024-05-29 |
| Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT06419634) | Bristol-Myers Squibb | 2024-05-29 |
| A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies (NCT06524687) | IGM Biosciences, Inc. | 2024-05-29 |
| A Study of GC203 TIL in Advanced Malignant Solid Tumors (NCT06375187) | Shanghai Juncell Therapeutics | 2024-05-29 |
| Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury (NCT06282965) | University of Arizona | 2024-05-28 |
| A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions (NCT06308679) | Pharma Nueva | 2024-05-28 |
| A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects. (NCT06481098) | Hanmi Pharmaceutical Company Limited | 2024-05-28 |
| A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NCT06470438) | Janssen Research & Development, LLC | 2024-05-28 |
| A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers (NCT06254495) | Seagen, a wholly owned subsidiary of Pfizer | 2024-05-28 |
| A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma (NCT06424626) | Peking University Cancer Hospital & Institute | 2024-05-28 |
| A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food (NCT06415045) | Boehringer Ingelheim | 2024-05-28 |